Comments

Bio-Path Holdings Stock Price, Quotes and Forecasts

Q: What sector and industry does Bio-Path Holdings (BPTH) operate in?

Bio-Path Holdings is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

BPTHOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.1971

At close: Jun 4, 4:00 PM EDT

$0.2000

0.002901.47%

Pre-Market: Jun 4, 4:00 PM EDT

Bio-Path Holdings (BPTH) Forecast

News Earnings Bio-Path Holdings (BPTH) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Bio-Path Holdings Stock Price, Quotes and Forecasts | OTC:BPTH | Benzinga

Explore Bio-Path Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BPTH.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	0.55
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

US Stocks Mixed; NY State Business Activity Rises In February

Avi Kapoor

Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline

Avi Kapoor

Bio-Path Holdings Shares Were On The Rise: What's Going On?

Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares are surging Thursday following the company's announcement of encouraging preclinical results for BP1001-A, a potential treatment for obesity and Type 2 diabetes. Here's what you need to know.

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	0.55
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About Bio-Path Holdings Inc

Sector

Health Care

Industry

Biotechnology

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug de...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bio-Path Holdings (BPTH) stock?

You can purchase shares of Bio-Path Holdings (OTCQB:BPTH) through any online brokerage.

View our list of the best stock brokerages

Who are Bio-Path Holdings (BPTH) competitors?

There are no as such competitors for Bio-Path Holdings.

What is the forecast, or price target, for Bio-Path Holdings (BPTH) stock?

Bio-Path Holdings has a consensus price target of $30.00.

What is the current price for Bio-Path Holdings (BPTH)?

The stock price for Bio-Path Holdings (OTCQB: BPTH) is $0.2 last updated June 4, 2025 at 4:00 PM EDT.

Does Bio-Path Holdings (BPTH) pay a dividend?

There are no upcoming dividends for Bio-Path Holdings.

When is Bio-Path Holdings (OTCQB:BPTH) reporting earnings?

Bio-Path Holdings’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Bio-Path Holdings (BPTH) going to split?

There is no upcoming split for Bio-Path Holdings.

What sector and industry does Bio-Path Holdings (BPTH) operate in?

Bio-Path Holdings is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.